Antireflux mucosectomy for gastroesophageal reflux disease: efficacy and the mechanism of action
Endoscopy · 01.12.2024 · 56 (12) · 897-905
DOI: 10.1055/a-2333-5232 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Endoscopy, erschienen am 01.12.2024. Verfasst von Thijs Kuipers und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Amsterdam UMC Location AMC, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Proton Pump Inhibitors, Esophageal pH Monitoring. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Previous studies suggested that antireflux mucosectomy (ARMS) is effective in reducing reflux symptoms and total acid exposure, although the mechanism is unknown. Our objective was to investigate the effect of ARMS on reflux parameters and its mechanism of action.
Methods
Gastroesophageal reflux disease (GERD) patients with insufficient symptom control despite a twice-daily proton pump inhibitor (PPI) underwent a piecemeal multiband mucosectomy of 50% of the circumference of the esophagogastric junction (EGJ), extending 2 cm into the cardia. The primary end point was the total number of reflux episodes during 24-hour pH-impedance studies.
Results
11 patients (8 men; median age 37 [interquartile range (IQR) 32–57] years) were treated, with one patient subsequently lost to follow-up. ARMS reduced the median (IQR) number of total reflux episodes (74 [60–82] vs. 37 [28–66]; P = 0.008) and total acid exposure time (8.7% [6.4%–12.7%] vs. 5.3% [3.5%–6.7%]; P = 0.03). Treatment reduced the median (IQR) number of transient lower esophageal sphincter relaxations (TLESRs) during a 90-minute postprandial period (4 [1–8] vs. 2 [1–4]; P = 0.03) and reflux symptom scores (3.6 [3.6–3.9] vs. 1.6 [0.7–2.7]; P = 0.005). Treatment did not increase the mean (SD) dysphagia scores (8.2 [7.3] vs. 8.5 [6.5]) or change the EGJ distensibility on impedance planimetry (4.4 [2.1] vs. 4.3 [2.2] mm2/mmHg). One delayed post-procedural bleed requiring repeat endoscopy occurred (10%); no strictures developed.
Conclusion
ARMS is an effective treatment option in PPI-refractory GERD, reducing acid exposure, reflux episodes, and symptoms. While its working mechanism could not be explained by a difference in distensibility, a reduction in TLESRs might play a role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Hepatology, Amsterdam UMC Location AMC, Amsterdam, Netherlands.
- Gastroenterology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.
ORCID-Profile: Thijs Kuipers
Zitieren
APA
Kuipers, T., Oude Nijhuis, R. A. B., Pouw, R. E., & Bredenoord, A. J. (2024). Antireflux mucosectomy for gastroesophageal reflux disease: efficacy and the mechanism of action. Endoscopy, 56(12), 897-905. https://doi.org/10.1055/a-2333-5232
Vancouver
Kuipers T, Oude Nijhuis RAB, Pouw RE, Bredenoord AJ. Antireflux mucosectomy for gastroesophageal reflux disease: efficacy and the mechanism of action. Endoscopy. 2024;56(12):897-905. doi:10.1055/a-2333-5232
BibTeX
@article{Kuipers2024,
author = {Kuipers, Thijs and Oude Nijhuis, Renske A B and Pouw, Roos E and Bredenoord, Albert J},
title = {Antireflux mucosectomy for gastroesophageal reflux disease: efficacy and the mechanism of action},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {12},
pages = {897--905},
doi = {10.1055/a-2333-5232}
}
EUVIMED